-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EyQ5I2yxO78w2hFqjsGpqv+LQTajLgzdhgOJTgVNAgqohBZvvnkrS1Du4YF3P6GZ 2wZ1jD2+8TkRowzr66B24w== 0000928475-08-000174.txt : 20080515 0000928475-08-000174.hdr.sgml : 20080515 20080515162436 ACCESSION NUMBER: 0000928475-08-000174 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080515 DATE AS OF CHANGE: 20080515 EFFECTIVENESS DATE: 20080515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICAHN CAPITAL LP CENTRAL INDEX KEY: 0001412093 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12848 FILM NUMBER: 08838076 BUSINESS ADDRESS: STREET 1: 445 HAMILTON AVENUE STREET 2: SUITE 1210 CITY: WHITE PLAINS STATE: NY ZIP: 10601 BUSINESS PHONE: 914-614-7000 MAIL ADDRESS: STREET 1: 445 HAMILTON AVENUE STREET 2: SUITE 1210 CITY: WHITE PLAINS STATE: NY ZIP: 10601 FORMER COMPANY: FORMER CONFORMED NAME: ICAHN PARTNERS HOLDING LP DATE OF NAME CHANGE: 20070911 13F-HR 1 frm13fhricahncapital33108.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2008 Check here if Amendment [ ]; Amendment Number This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report. Name: Icahn Capital LP Address: 445 Hamilton Avenue, Suite 1210 White Plains, New York 10601 Form 13F File Number: 28-12848 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statement, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Andrew Skobe Title: Interim Chief Financial Officer of Icahn Enterprises G.P. Inc., the general partner of Icahn Enterprises Holdings L.P., the sole member of IPH GP LLC, the general partner of Icahn Capital LP Phone: (212) 702-4300 Signature, Place, and Date of Signing: /s/Andrew Skobe - --------------- Andrew Skobe New York, New York 05/15/08 [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT: (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 26 Form 13F Information Table Value Total: $4,642,985 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name --- -------------------- ----
Form 13F Information Table Name of Reporting Manager: Icahn Capital LP COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 NAME OF TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER Voting Authority ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE - ------ ----- ----- -------- ------- --- ---- ---------- ------- ---- ------ ---- ADVENTRX PHARMA- COM 00764X103 1,868 3,459,459 SH Sole n/a 3,459,459 CEUTICALS INC AMICUS THERA- COM 03152W109 2,161 201,940 SH Sole n/a 201,940 PEUTICS INC AMYLIN PHARMA- COM 032346108 185,181 6,339,653 SH Sole n/a 6,339,653 CEUTICALS ANADARKO PETE COM 032511107 907,735 14,401,628 SH Sole n/a 14,401,628 CORP APPLERA COM APP 038020103 21,327 649,026 SH Sole n/a 649,026 CORP BIO GRP BEA SYS INC COM 073325102 793,883 41,456,016 SH Sole n/a 41,456,016 BIOGEN IDEC INC COM 09062X103 613,737 9,948,723 SH Sole n/a 9,948,723 BLOCKBUSTER INC CL A 093679108 34,308 10,523,840 SH Sole n/a 10,523,840 BLOCKBUSTER INC CL B 093679207 12,691 4,452,905 SH Sole n/a 4,452,905 CYBERONICS INC COM 23251P102 29,125 2,008,612 SH Sole n/a 2,008,612 ELLIS PERRY COM 288853104 2,832 129,715 SH Sole n/a 129,715 INTL INC ENZON PHARMA- COM 293904108 22,635 2,457,683 SH Sole n/a 2,457,683 CEUTICALS INC FORESTAR REAL COM 346233109 66,087 2,653,012 SH Sole n/a 2,653,012 ESTATE GROUP INC GUARANTY FINL COM 40108N106 28,175 2,653,012 SH Sole n/a 2,653,012 GROUP INC LEAR CORP COM 521865105 248,631 9,595,954 SH Sole n/a 9,595,954 LIONS GATE COM 535919203 41,823 4,289,508 SH Sole n/a 4,289,508 ENTMNT CORP NEW MOTOROLA INC COM 620076109 1,075,541 115,649,600 SH Sole n/a 115,649,600 PENNEY J C INC COM 708160106 3,017 80,000 SH Sole n/a 80,000 QUEST RESOURCE COM 748349305 5,703 868,002 SH Sole n/a 868,002 CORP NEW REGENERON PHARMA- COM 75886F107 48,129 2,508,001 SH Sole n/a 2,508,001 CEUTICALS TELIK INC COM 87959M109 10,142 4,156,663 SH Sole n/a 4,156,663 TEMPLE INLAND INC COM 879868107 43,865 3,448,488 SH Sole n/a 3,448,488 TIME WARNER CABLE CL A 88732J108 117,684 4,711,128 SH Sole n/a 4,711,128 INC TIME WARNER INC COM 887317105 181,323 12,933,159 SH Sole n/a 12,933,159 WCI CMNTYS INC COM 92923C104 16,135 4,816,450 SH Sole n/a 4,816,450 WILLIAMS COS INC COM 969457100 129,247 3,918,959 SH Sole n/a 3,918,959 Total: $4,642,985
-----END PRIVACY-ENHANCED MESSAGE-----